𝔖 Bobbio Scriptorium

✦ LIBER ✦

The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: A matched-paired retrospective analysis using coronary angiography as the diagnostic tool

✍ Scribed by G.D. Fallow; Jaipaul Singh

Book ID: 111598675
Publisher: Springer
Year: 2004
Tongue: English
Weight: 99 KB
Volume: 261
Category: Article
ISSN: 0300-8177
DOI: 10.1023/b:mcbi.0000028764.01670.30

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of developing coronary artery d

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

✍ Kevin M. Pantalone; Michael W. Kattan; Changhong Yu; Brian J. Wells; Susana Arri 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 286 KB

Hemoglobin A1cvariability as an independ

Hemoglobin A1cvariability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study

✍ Penno, Giuseppe; Solini, Anna; Zoppini, Giacomo; Orsi, Emanuela; Fondelli, Cecil 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 232 KB

Pantalone et al.: The risk of developing

Pantalone et al.: The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

✍ David S. H. Bell 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 75 KB

PDB25 COST OF ALL-CAUSE AND CARDIOVASCUL

PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN: A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE

✍ J.H. Best; E. Pelletier; D.B. Smith 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Letter to the Editor re: the Letter to t

Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis”

✍ Robert S. Zimmerman; Kevin Matthew Pantalone 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 82 KB